A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Jerby-Arnon, Livnat, Shah, Parin, Cuoco, Michael S., Rodman, Christopher, Su, Mei-Ju, Melms, Johannes C., Leeson, Rachel, Kanodia, Abhay +44 more·2018·Cell

DOI 10.1016/j.cell.2018.09.006

Cited by (999)

Items 301–400 of 999

The current landscape of single-cell transcriptomics for cancer immunotherapy
Puneeth Guruprasad, Yong Gu Lee, Ki Hyun Kim, Marco Ruella · 2020 · The Journal of Experimental Medicine
Network models of primary melanoma microenvironments identify key melanoma regulators underlying prognosis
Song, Won-Min, Agrawal, Praveen, Von Itter, Richard, Fontanals-Cirera, Barbara, Wang, Minghui, Zhou, Xianxiao, Mahal, Lara K., Hernando, Eva, Zhang, Bin · 2021 · Nature Communications
A T cell resilience model associated with response to immunotherapy in multiple tumor types
Yu Zhang, Trang Vu, Douglas C. Palmer, Rigel J. Kishton, Lanqi Gong, Jiao Huang, Thanh Nguyen, Zuojia Chen, Cari Smith, Ferenc Livák et al. · 2022 · Nature Medicine
Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
Alexander Noor Shoushtari, Anthony J. Olszanski, Marta Nyakas, Thomas J. Hornyak, Jedd D. Wolchok, Victor Levitsky, Łukasz Kuryk, Thomas B. Hansen, Magnus Erik Jaderberg · 2022 · Clinical Cancer Research
Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1
Keywan Mortezaee, Jamal Majidpoor · 2023 · Biomedicine & Pharmacotherapy
Cell Cycle Regulation Meets Tumor Immunosuppression
Jinyang Li, Ben Z. Stanger · 2020 · Trends in Immunology
Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications
Wei Sun, Qing Zhang, Runkun Wang, Li Yang, Yue Sun, Lin Yang · 2021 · Frontiers in Oncology
Defining and using immune archetypes to classify and treat cancer
Alexis J. Combes, Bushra Samad, Matthew F. Krummel · 2023 · Nature reviews. Cancer
Disrupting cellular memory to overcome drug resistance
Guillaume Harmange, Raúl A. Reyes Hueros, Dylan L. Schaff, Benjamin L. Emert, Michael Saint-Antoine, Laura C. Kim, Zijian Niu, Shivani Nellore, Mitchell E. Fane, Gretchen Marie Alicea et al. · 2023 · Nature Communications
Application of single-cell and spatial omics in deciphering cellular hallmarks of cancer drug response and resistance
Xiaoxia Cheng, Ting Peng, Tian Chu, Yiqun Yang, Jia Liu, Qinglei Gao, Canhui Cao, Juncheng Wei · 2025 · Journal of Hematology & Oncology
Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells
Carlos Aya‐Bonilla, Michael Morici, Xin Hong, Ashleigh Cavell McEvoy, Ryan Joseph Sullivan, James B. Freeman, Leslie Calapre, Muhammad Adnan Khattak, Tarek M. Meniawy, Michael Millward et al. · 2020 · British Journal of Cancer
Unraveling the Complexity of the Cancer Microenvironment With Multidimensional Genomic and Cytometric Technologies
Natasja L. De Vries, Ahmed Essam Mahfouz, Frits Koning, Noel F.C.C. de Miranda · 2020 · Frontiers in Oncology
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma
Roberto Vendramin, Vicky Katopodi, Sonia Cinque, Angelina Konnova, Zorica Knezevic, Sara Adnane, Yvessa Verheyden, Panagiotis Karras, Ewout Demesmaeker, Francesca Maria Bosisio et al. · 2021 · The Journal of Experimental Medicine
Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities
Davood Bashash, Zahra Zandi, Bahareh Kashani, Atieh Pourbagheri‐Sigaroodi, Sina Salari, Seyed Hamidollah Ghaffari · 2021 · Journal of Cellular Physiology
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses
Gabrielle Romain, Paolo Strati, Ali Rezvan, Mohsen Fathi, Irfan N. Bandey, Jay R T. Adolacion, Darren Heeke, Ivan Liadi, Mario Luiz Marques-Piubelli, Luisa Maren Solis et al. · 2022 · Journal of Clinical Investigation
Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer
James John Asciolla, Xuewei Wu, Christos Adamopoulos, Evripidis Gavathiotis, Poulikos I. Poulikakos · 2025 · Nature Cancer
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
Christof C. Smith, Shengjie Chai, Amber R. Washington, Samuel J. Lee, Elisa Landoni, Kevin P. Field, Jason A. Garness, Lisa M. Bixby, Sara R. Selitsky, Joel S. Parker et al. · 2019 · Cancer Immunology Research
Investigating Tumor Heterogeneity in Mouse Models
Tuomas Tammela, Julien Sage · 2019 · Annual Review of Cancer Biology
Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
Jo Waaler, Line Mygland, Anders Aune Tveita, Martin Frank Strand, Nina Therese Solberg, Petter Angell Olsen, Aleksandra Aizenshtadt, Marte Fauskanger, Kaja Lund, Shoshy Alam Brinch et al. · 2020 · Communications Biology
Decoding Cancer Biology One Cell at a Time
L. Nicolas Gonzalez Castro, Itay Tirosh, Mario L. Suvà · 2021 · Cancer Discovery
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling
Georgi Apriamashvili, David W. Vredevoogd, Oscar Krijgsman, Onno B. Bleijerveld, Maarten Alexander Ligtenberg, Beaunelle de Bruijn, Julia Boshuizen, Joleen J.H. Traets, Daniela M. D'Empaire Altimari, Alex v. Vliet et al. · 2022 · Nature Communications
Angiopoietin-2–Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma
Ha-Ram Park, Anahita Shiva, Portia Cummings, Seoyeon Kim, Sungsoo Kim, Eunhyeong Lee, Alessandra Leong, Subrata Chowdhury, Carrie J. Shawber, Richard D. Carvajal et al. · 2023 · Cancer Research
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
James M. Isaacs, Carey K. Anders, Heather L. McArthur, Jeremy Meyer Force · 2021 · Current Treatment Options in Oncology
Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti–PD-1 Therapy
Kun Wang, Sushant Patkar, Joo Sang Lee, E. Michael Gertz, Welles Robinson, Fiorella Schischlik, David R. Crawford, Alejandro A. Schäffer, Eytan Ruppin · 2022 · Cancer Discovery
DENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing
Zilu Zhou, Bihui Xu, Andy J. Minn, Nancy Ruonan Zhang · 2020 · Genome biology
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens
Yiping Wang, Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera, Patricia Ho, Somnath Tagore, Gabriel Abril-Rodríguez, Siyu He et al. · 2023 · Nature Genetics
Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells
Jenny Sprooten, Isaure Vanmeerbeek, Angeliki Datsi, Jannes Govaerts, Stefan Naulaerts, Raquel Salvador Laureano, Daniel Borràs, Anna Calvet, Vanshika Malviya, Marc Kuballa et al. · 2024 · Cell Reports Medicine
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma
Johanna Chiffelle, David Barras, Rémy Pétremand, Angela Orcurto, Sara Bobisse, Marion Arnaud, Aymeric Auger, Blanca Navarro Rodrigo, Eleonora Ghisoni, Christophe Sauvage et al. · 2024 · Immunity
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms
Charles W. Abbott, Sean M. Boyle, Rachel Marty Pyke, Lee McDaniel, Éric Levy, Fábio C. P. Navarro, Dattatreya Mellacheruvu, Simo V. Zhang, Mengyao Tan, Rose Santiago et al. · 2021 · Clinical Cancer Research
Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma
Wenjin Chen, Keqin Dong, Xiuwu Pan, Sishun Gan, Da Xu, Jia-xin Chen, Weijie Chen, Wenyan Li, Yuqi Wang, Zhou Wang et al. · 2023 · Cell Death and Disease
Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors
Piotr Wawrzyniak, Mariusz L. Hartman · 2025 · Molecular Cancer
Mechanical confinement governs phenotypic plasticity in melanoma
Miranda V. Hunter, Eshita Joshi, Sydney Bowker, Emily D. Montal, Yilun Ma, Young Hun Kim, Zhifan Yang, Laura Tuffery, Zhuoning Li, Eric Rosiek et al. · 2025 · Nature
The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy
Kostyantyn Krysan, Linh My Tran, Brandon S. Grimes, Gregory A. Fishbein, Atsuko Seki, Brian K. Gardner, Tonya C. Walser, Ramin Salehi‐Rad, Jane Yanagawa, Jay M. Lee et al. · 2019 · Cancer Research
The Tumor Microenvironment of Colorectal Cancer Metastases: Opportunities in Cancer Immunotherapy
Yasmin Kamal, Stephanie L. Schmit, Hildreth Robert Frost, Christopher Ian Amos · 2020 · Immunotherapy
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial
Toni K. Choueiri, James Larkin, Sumanta Kumar Pal, Robert John Motzer, Brian I. Rini, Balaji Venugopal, B. Yа. Alekseev, Hideaki Miyake, Gwénaëlle Gravis, Mehmet Asım Bilen et al. · 2021 · ESMO Open
AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells
Natacha Comandante-Lou, Douglas G. Baumann, Mohammad Fallahi‐Sichani · 2022 · Cell Reports
Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes
Jiaqiang Xiong, Lu Dong, Qiongying Lv, Yutong Yin, Jiahui Zhao, Youning Ke, Shixuan Wang, Wei Zhang, Meng Wu · 2024 · Clinical and Translational Medicine
Scalable spatial single-cell transcriptomics and translatomics in 3D thick tissue blocks
Xin Sui, Jennifer A. Lo, Shuchen Luo, Yichun He, Zefang Tang, Zuwan Lin, Dániel L. Barabási, Yiming Zhou, Wendy Xueyi Wang, Jia Liu B et al. · 2025 · Nature Methods
Single-cell RNA sequencing of immune cells in gastric cancer patients
Kai Fu, Bingqing Hui, Qian Wang, Lu Chen, Weihong Shi, Zhigang Zhang, Dawei Rong, Betty Zhang, Zhaofeng Tian, Weiwei Tang et al. · 2020 · Aging
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S. Grasso, Jennifer Tsoi, Mykola I. Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo, Ameya S. Champhekar, Egmidio Medina, Davis Yuri Torrejon, Daniel Sanghoon Shin et al. · 2020 · Cancer Cell
Uncovering hypergraphs of cell-cell interaction from single cell RNA-sequencing data
Koki Tsuyuzaki, Manabu Ishii, Itoshi Nikaido · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer
Rumana Rashid, Giorgio Gaglia, Yu-An Chen, Jia‐Ren Lin, Ziming Du, Zoltan Maliga, Denis Schapiro, Clarence Yapp, Jeremy L. Muhlich, Artem Sokolov et al. · 2019 · Scientific Data
Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
Lara Gibellini, Sara De Biasi, Camillo Porta, Domenico Lo Tartaro, Roberta Depenni, Giovanni Pellacani, Roberto Sabbatini, Andrea Cossarizza · 2020 · Frontiers in Immunology
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Joaquim Bellmunt B, Ronald de Wit, Yves Fradet, Miguel A. Climent, Daniel P. Petrylak, Jae-Lyun Lee, Lawrence H. Fong, Andrea Necchi, Cora N. Sternberg, Peter H. O'Donnell et al. · 2022 · Clinical Cancer Research
Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity
Jacqueline A. Turner, Malia A. Fredrickson, Marc A. D’Antonio, Elizabeth N. Katsnelson, Morgan L. MacBeth, Robert J. Van Gulick, Tugs-Saikhan Chimed, Martin McCarter, Angelo D’Alessandro, William Allen Robinson et al. · 2023 · Nature Communications
Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma
Weifeng Hong, Yang Zhang, Siwei Wang, Dan-Xue Zheng, Shu-Jung Hsu, Jian Zhou, Jia Fan, Zhao‐Chong Zeng, Nan Wang, Zhiyong Ding et al. · 2023 · Cancer Letters
Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor
Sean D. Allen, Xiangsheng Liu, Jinhong Jiang, Yu‐Pei Liao, Chong Hyun Chang, André E. Nel, Huan Meng · 2020 · Biomaterials
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition
Christopher A Alvarez-Breckenridge, Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matt Lastrapes, Matthew R. Strickland, Albert Eusik Kim, Magali A. de Sauvage, Ashish Dahal, Juliana M. Larson et al. · 2022 · Cancer Immunology Research
Immunosenescence, inflammaging, and cancer immunotherapy efficacy
Julieta E. Rodriguez, Marie Naigeon, Vincent Goldschmidt, Matthieu Roulleaux Dugage, Lauren Seknazi, François‐Xavier Danlos, Stéphane Champiat, Aurélien Marabelle, Jean‐Marie Michot, Christophe Massard et al. · 2022 · Expert Review of Anticancer Therapy
M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
Naisheng Zheng, Tingting Wang, Qin Luo, Yi Liu, Junyao Yang, Yunlan Zhou, Guohua Xie, Yanhui Ma, Xiangliang Yuan, Lisong Shen · 2023 · OncoImmunology
Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy
Bicheng Ye, Aimin Jiang, Liang Feng, Changcheng Wang, Xiaoqing Liang, Pengpeng Zhang · 2024 · BioFactors
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort
Jose Ricardo McFaline-Figueroa, Lu Sun, Gilbert Youssef, Raymond Y. Huang, Gang Li, Jiyoon Kim, Eudocia Q. Lee, Lakshmi Nayak, Ugonma Nnenna Chukwueke, Rameen Beroukhim et al. · 2024 · Nature Communications
Biomarkers for Response to Immune Checkpoint Blockade
Ganesan, Shridar, Mehnert, Janice · 2020 · Annual Review of Cancer Biology
Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment
Junge Bai, Hongsheng Chen, Xuefeng Bai · 2021 · Journal of Clinical Laboratory Analysis
Applications of Single-Cell Omics in Tumor Immunology
Junwei Liu, Saisi Qu, Tongtong Zhang, Yufei Gao, Hongyu Shi, Kaichen Song, Wei Chen, Weiwei Yin · 2021 · Frontiers in Immunology
Identification and Utilization of Biomarkers to Predict Response to Immune Checkpoint Inhibitors
Ole V. Gjoerup, Charlotte A. Brown, Jeffrey S. Ross, Richard S.P. Huang, Alexa Betzig Schrock, James Creeden, David A. Fabrizio, Khaled A. Tolba · 2020 · The AAPS Journal
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
Liye Zhou, Zexian Zeng, Ann Marie Egloff, Fan Zhang, Fei Guo, Katie Marie Campbell, Peter P. Du, Jingxin Fu, Paul Zolkind, Xiaojing Ma et al. · 2022 · Journal for ImmunoTherapy of Cancer
Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes
Renda Li, Zhenlin Yang, Fei Shao, Hong Sheng Cheng, Yaru Wen, Sijin Sun, Wei Guo, Zitong Li, Fan Zhang, Liyan Xue et al. · 2021 · Nature Communications
Mapping Breast Cancer Microenvironment Through Single-Cell Omics
Zhenya Tan, Kan Chen, Minqiong Sun, Fan Yang, Mandy Wong, Siying Wang, Hong Zheng · 2022 · Frontiers in Immunology
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
Rachael M. Zemek, Wee Loong Chin, Vanessa S. Fear, Ben Wylie, Thomas H. Casey, Cath Forbes, Caitlin M. Tilsed, Louis Boon, Belinda B. Guo, Anthony Bosco et al. · 2022 · Nature Communications
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma
Zhicheng Zhou, Mei-Ju May Chen, Yikai Luo, Kamalika Mojumdar, Xin Peng, Hu Chen, Shweta V. Kumar, Rehan Akbani, Yiling Lu, Han Liang · 2022 · Cancer Cell
Emerging clinical applications of single-cell RNA sequencing in oncology
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, Noam Galili Darnell, Alissa Greenwald, Rouven Hoefflin, Daniel Kovarsky, Dor Simkin, Shira Turgeman, Lingling Zhang et al. · 2025 · Nature Reviews Clinical Oncology
Identifying cell types to interpret scRNA-seq data: how, why and more possibilities
Ziwei Wang, Hui Ding, Quan Zou · 2020 · Briefings in Functional Genomics
Improving anti-PD-L1 therapy in triple negative breast cancer by polymer-enhanced immunogenic cell death and CXCR4 blockade
Minglu Zhou, Chaohui Luo, Zhou Zhou, Lian Li, Yuan Huang · 2021 · Journal of Controlled Release
All is not lost: learning from 9p21 loss in cancer
Pavlina Spiliopoulou, S.Y. Cindy Yang, Jeff P. Bruce, Ben X. Wang, Hal K. Berman, Trevor J. Pugh, Lillian L. Siu · 2022 · Trends in Immunology
Targeting CDK4 and 6 in Cancer Therapy: Emerging Preclinical Insights Related to Abemaciclib
Seth Andrew Wander, Neil A. O’Brien, Lacey M. Litchfield, Declan O’Dea, Claudia Morato Guimaraes, Dennis J. Slamon, Shom Goel · 2022 · The Oncologist
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
Selene E. Di Carlo, Jérôme Raffenne, Hugo Varet, A Ode, David Cabrerizo Granados, Merle Stein, Rachel Legendre, Jan Peter Tuckermann, Corinne Bousquet, Lucie Peduto · 2023 · Nature Immunology
RNA Sequencing of the Tumor Microenvironment in Precision Cancer Immunotherapy
Denise Lau, Alexandria M. Bobe, Aly Azeem Khan · 2019 · Trends in cancer
An elastic-net logistic regression approach to generate classifiers and gene signatures for types of immune cells and T helper cell subsets
Arezo Torang, Paraag Gupta, David J. Klinke · 2019 · BMC Bioinformatics
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes
Carla Calagua, Miriam Ficial, Caroline Stewart Jansen, Taghreed Hirz, Luke del Balzo, Scott C. Wilkinson, Ross G. Lake, Anson T. Ku, Olga S. Voznesensky, David B. Sykes et al. · 2021 · Clinical Cancer Research
Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma
Min Yan, Jing Hu, Yanyan Ping, Liwen Xu, Gaoming Liao, Zedong Jiang, Bo Pang, Shangqin Sun, Yunpeng Zhang, Yun Xiao et al. · 2021 · Frontiers in Immunology
Enabling Single‐Cell Drug Response Annotations from Bulk RNA‐Seq Using SCAD
Zetian Zheng, Junyi Chen, Xingjian Chen, Lei Huang, Weidun Xie, Qiuzhen Lin, Xiangtao Li, Ka‐Chun Wong · 2023 · Advanced Science
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
Wei Zhang, Yongwei Zhu, Hongyi Liu, Yihao Zhang, Hongwei Liu, Abraham Ayodeji Adegboro, Ruiyue Dang, Luohuan Dai, Siyi Wanggou, Xuejun Li · 2024 · npj Precision Oncology
Pan-cancer human brain metastases atlas at single-cell resolution
Xudong Xing, Jian Zhong, Jana Biermann, Hao Duan, Xinyu Zhang, Yu Shi, Yixin Gao, Kejun He, Duanyang Zhai, Feng Luo et al. · 2025 · Cancer Cell
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma
Luigi Fattore, Ciro Francesco Ruggiero, Domenico Liguoro, Rita Mancini, Gennaro Ciliberto · 2019 · Cell Death and Disease
Personalized Immuno-Oncology
Kewal K. Jain · 2020 · Medical Principles and Practice
Evaluating the transcriptional fidelity of cancer models
Da Peng, Rachel Gleyzer, Wen-Hsin Tai, Pavithra Kumar, Qin Bian, Bradley Isaacs, Edroaldo Lummertz da Rocha, Stephanie Cai, Kathleen T. DiNapoli, Franklin W. Huang et al. · 2021 · Genome Medicine
Dual mitigation of immunosuppression combined with photothermal inhibition for highly effective primary tumor and metastases therapy
Ju Huang, Liang Zhang, Weichen Zhou, Jingxue Wang, Ruo Zhang, Zhigang Wang, Haitao Ran, Pan Li, Rui Li · 2021 · Biomaterials
Comparison of cell type distribution between single-cell and single-nucleus RNA sequencing: enrichment of adherent cell types in single-nucleus RNA sequencing
Jin‐Mi Oh, Minae An, Dae‐Soon Son, Jinhyuk Choi, Yong Beom Cho, Chang Eun Yoo, Woong‐Yang Park · 2022 · Experimental & Molecular Medicine
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
Shamik Mitra, Martin Lauss, Rita Cabrita, Jiyeon Choi, Tongwu Zhang, Karolin Isaksson, Hakan Lars Olsson, Christian Ingvar, Ana Carneiro, Johan Staaf et al. · 2020 · Molecular Oncology
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
Vera Petrova, Ihor Arkhypov, Rebekka Weber, Christopher Groth, Peter Altevogt, Jochen Sven Utikal, Viktor Umansky · 2020 · International Journal of Molecular Sciences
Targeting TANK-binding kinase 1 (TBK1) in cancer
Or‐Yam Revach, Shuming Liu, Russell William Jenkins · 2020 · Expert Opinion on Therapeutic Targets
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma
Kuang Du, Shiyou Wei, Zhi Wei, Dennie Tompers Frederick, Benchun Miao, Tabea O. C. Moll, Tian Tian, Eric T. Sugarman, Dmitry I. Gabrilovich, Ryan Joseph Sullivan et al. · 2021 · Nature Communications
Profiling of immune features to predict immunotherapy efficacy
Youqiong Ye, Yongchang Zhang, Nong Yang, Qian Gao, Xinyu Ding, Xinwei Kuang, Rujuan Bao, Zhao Zhang, Chaoyang Sun, Bingying Zhou et al. · 2021 · The Innovation
Single‐cell transcriptomics in human skin research: available technologies, technical considerations and disease applications
Georgios Theocharidis, Stavroula Tekkela, Aristidis Veves, John Alexander McGrath, Alexandros Onoufriadis · 2022 · Experimental Dermatology
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
Valentin Benboubker, Félix Boivin, Stéphane Dalle, Julie Caramel · 2022 · Frontiers in Immunology
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics
Wendi Liu, Anusha Puri, Doris Fu, Lee Chen, Cassia Wang, M Kellis, Jiekun Yang · 2023 · Clinical & Experimental Metastasis
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
Marcella Tazzari, Laura Bergamaschi, Alessandro De Vita, Paola Collini, Marta Barisella, Alessia Bertolotti, Toni Ibrahim, Sandro Pasquali, Chiara Castelli, Viviana Vallacchi · 2021 · International Journal of Molecular Sciences
Preclinical models and technologies to advance nanovaccine development
Carina Peres, Ana I. Matos, Liane I.F. Moura, Rita C. Acúrcio, Bárbara Carreira, Sabina Pozzi, Daniella Vaskovich‐Koubi, Ron Kleiner, Ronit Satchi‐Fainaro, Helena F. Florindo · 2021 · Advanced Drug Delivery Reviews
Single-cell and spatial analyses of cancer cells: toward elucidating the molecular mechanisms of clonal evolution and drug resistance acquisition
Satoi Nagasawa, Yukie Kashima, Ayako Suzuki, Yutaka Suzuki · 2021 · Inflammation and Regeneration
Mapping and Validation of scRNA-Seq-Derived Cell-Cell Communication Networks in the Tumor Microenvironment
Kate Bridges, Kathryn Miller‐Jensen · 2022 · Frontiers in Immunology
Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis
Bridget P. Keenan, Elizabeth E. McCarthy, Arielle Ilano, Hai Yang, Li Zhang, Kathryn M. Allaire, Zenghua Fan, Tony Yi‐Wei Li, David S. Lee, Yang Sun et al. · 2022 · Cell Reports
EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
Andreas Hippe, Stephan Alexander Braun, Péter Oláh, Peter Arne Gerber, Anne Schorr, Stephan Seeliger, Stephanie Holtz, Katharina Jannasch, Andor Pivarcsi, Bettina Alexandra Buhren et al. · 2020 · British Journal of Cancer
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models
Robert J. Torphy, Yi Sun, Ronggui Lin, Alayna K. Caffrey-Carr, Yuki Fujiwara, Felix Ho, Emily N. Miller, Martin D. McCarter, Traci Renae Lyons, Richard David Schulick et al. · 2022 · Nature Communications
An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields
Sven Beyes, Naiara G. Bediaga, Alessio Zippo · 2021 · Cancers
Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication
Dongjie Chen, Pengyi Liu, Xiongxiong Lu, Jingfeng Li, Debin Qi, Longjun Zang, Jiayu Lin, Yihao Liu, Shuyu Zhai, Da Fu et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology
Kirill V. Peskov, Ivan Azarov, Lulu Chu, Veronika Voronova, Yuri Kosinsky, Gabriel Helmlinger · 2019 · Frontiers in Immunology
Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors
Magdalena Olbryt, Marcin Rajczykowski, Wiesława Widłak · 2020 · International Journal of Molecular Sciences
Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment
Chen Chen, Yanlong Liu, Binbin Cui · 2021 · Human Vaccines & Immunotherapeutics
Meta-Analysis of Human Cancer Single-Cell RNA-Seq Datasets Using the IMMUcan Database
Jordi Camps, Floriane Noël, Robin Liechti, Lucile Massenet-Regad, Sidwell Rigade, Lou Götz, Caroline Hoffmann, Elise Amblard, Mélissa Saichi, Mahmoud M. Ibrahim et al. · 2022 · Cancer Research